Palo Alto Networks has announced that its buying Tel Aviv-based Cyvera for $US200 million, including $US88 million in cash.
The attraction is the Israeli company’s TRAPS (Targeted Remote Attack Prevention System), an endpoint protection system for Windows machines, which PAN will add to its existing firewall and cloud security products.
PAN’s blog post about the acquisition makes the bold claim that Cyvera has “successfully stopped every published zero-day attack since they first began deploying their product”.
Announcing the acquisition, PAN’s CEO Mark McLaughlin tagged endpoint security as a market worth between $US4 billion and $US5 billion.
Details on the operation of Cyvera’s technology are sketchy, but according to the San Jose Mercury News, it impressed PAN’s co-founder Nir Zuk, who said the normal zero-day attack toolkit is “limited to about 20 different techniques … what Cyvera does is basically blocks the bad guys from being able to use those techniques.”
Cyvera’s 55 staff will remain in Israel, and the acquisition is expected to be completed in the second half of the year. ®
Like this:
Like Loading...
Published by Charles Aunger
Charles Aunger is a proven cloud and enterprise technology innovator as well as a recognized pioneer in the digital transformation of healthcare IT. An international thought leader and industry visionary, he is a highly sought-after speaker at global healthcare industry events on topics that range from operational innovation and data liquidity to digital transformation strategy, AI and big data, and best practices in aligning business, technical, and operational needs at scale.
This pivotal role leverages his 15-year track record as a solutions expert responsible for the selection, implementation, and life cycle support of clinical, financial, and regulatory applications at scale. As executive director at Stanford Health Care, Charles led the innovation team that supported over 15,000 employees and enabled pivotal partnerships with leading organizations such as HPE, Intel, Apple and Microsoft. As senior vice president at Cleveland Clinical Abu Dhabi, he directed the strategic planning and tactical execution efforts of a 175-person IT team, charged with balancing costs, solutions and business model requirements for a £3 billion technical solution in a 300,000+ user project.
A noted IT strategist, Charles previously served in executive IT roles Up to CTO at major technology-driven organizations around the globe including Mubadala, Accenture, Citrix, NHS, Numonyx, and Bupa.
He also freely shares his expertise and provides executive guidance to technology start-ups; at present, is also an advisor to Health2047, a board member, industry advisor, mentor, Fellow at the British Computer Society (BCS) and a member of the Forbes Technology Council.
View all posts by Charles Aunger
